SCHEMBL9683292

SCHEMBL9683292

CC(Cc1ccc(C(N)=O)s1)NCC(O)COc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 9/20 0.57
ADRB3 P13945 9/20 0.57
ADRB2 P07550 7/20 0.57
CYP2D6 P10635 2/20 0.53
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 1/20 0.52
DPP4 P27487 2/20 0.48
LMNA P02545 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
CNR1 P21554 1/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.46
GLA P06280 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683298 1.00 ADRB1 (0.57) ADRB1ADRB3ADRB2CYP2D6MEN1
SCHEMBL9684249 0.89 MEN1 (0.61) ADRB1ADRB3ADRB2CYP2D6MEN1
SCHEMBL9684254 0.89 MEN1 (0.61) ADRB1ADRB3ADRB2CYP2D6MEN1
SCHEMBL9685324 0.85 ADRB3 (0.54) ADRB1ADRB3ADRB2CYP2D6MEN1
SCHEMBL10725804 0.81 ADRB1 (0.52) ADRB1ADRB3ADRB2CYP2D6ALDH1A1
SCHEMBL10725792 0.81 ADRB1 (0.52) ADRB1ADRB3ADRB2CYP2D6ALDH1A1
SCHEMBL10725811 0.81 ADRB1 (0.52) ADRB1ADRB3ADRB2CYP2D6ALDH1A1
SCHEMBL10725798 0.81 ADRB1 (0.52) ADRB1ADRB3ADRB2CYP2D6ALDH1A1
SCHEMBL9787439 0.80 ABCB1 (0.46) ADRB1ADRB3ADRB2CYP2D6MEN1
SCHEMBL9787435 0.80 ABCB1 (0.46) ADRB1ADRB3ADRB2CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed